TGFB1 and cancer: Based on immune subtype theory, patients across cancer types can be identified into six immunological subtypes denoted C1–C6, corresponding to wound healing, IFN-γ dominant, inflammatory, lymphocyte depleted, immunologically quiet, and TGF-β dominant (36).